Improvement of Targeted Chemotherapy of HER2-positive Ovarian Malignant Cell Line by Z(HER2)-Idarubicin Conjugate: An in vitro Study

BACKGROUND & OBJECTIVE: Overexpression of human epidermal growth factor receptor 2 (HER2) causes cell transformation and development of various types of malignancies. Idarubicin is an effective anti-neoplastic drug but its specific delivery to the targeted cells is still a great challenge. Affib...

Descripción completa

Detalles Bibliográficos
Autores principales: Siavoshinia, Leila, Jamalan, Mostafa, Zeinali, Majid, Pourshohod, Aminollah, Koushki, Mahdie, Moradipoodeh, Bahman, Mohammadzadeh, Ghorban
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Iranian Society of Pathology 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8085286/
https://www.ncbi.nlm.nih.gov/pubmed/33936221
http://dx.doi.org/10.30699/IJP.2020.120392.2310

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8085286/
https://www.ncbi.nlm.nih.gov/pubmed/33936221
http://dx.doi.org/10.30699/IJP.2020.120392.2310

Ejemplares similares